{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:49:19Z","timestamp":1787028559182,"version":"build-2736575974"},"reference-count":88,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Autoimmune liver diseases involve a heterogeneous group of chronic inflammatory disorders, including autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis. Sometimes presented consistently as an overlapping syndrome, their pathogenesis is rather complex and has yet to be fully elucidated, despite extensive research efforts. This review article corroborates the molecular mechanisms of autoimmune liver diseases, as well as existing and potential therapeutic modalities.<\/jats:p>","DOI":"10.3390\/ijms26051863","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:26:32Z","timestamp":1740129992000},"page":"1863","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Closer Look into Autoimmune Liver Diseases"],"prefix":"10.3390","volume":"26","author":[{"given":"Branka","family":"Filipovic","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Clinical and Hospital Center \u201cDr Dragisa Misovic-Dedinje\u201d, Heroja Milana Tepica 1, 11020 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, Dr Subotica Starijeg 8, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7053-9034","authenticated-orcid":false,"given":"Marija","family":"Marjanovic-Haljilji","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Clinical and Hospital Center \u201cDr Dragisa Misovic-Dedinje\u201d, Heroja Milana Tepica 1, 11020 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Blagojevic","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Clinical and Hospital Center \u201cDr Dragisa Misovic-Dedinje\u201d, Heroja Milana Tepica 1, 11020 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Dragovic","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Clinical and Hospital Center \u201cDr Dragisa Misovic-Dedinje\u201d, Heroja Milana Tepica 1, 11020 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilija","family":"Krsmanovic","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Clinical and Hospital Center \u201cDr Dragisa Misovic-Dedinje\u201d, Heroja Milana Tepica 1, 11020 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Matovic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Clinical and Hospital Center \u201cDr Dragisa Misovic-Dedinje\u201d, Heroja Milana Tepica 1, 11020 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Panic","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Clinical and Hospital Center \u201cDr Dragisa Misovic-Dedinje\u201d, Heroja Milana Tepica 1, 11020 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanimir","family":"Kiurski","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Clinical and Hospital Center \u201cDr Dragisa Misovic-Dedinje\u201d, Heroja Milana Tepica 1, 11020 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zagor","family":"Zagorac","sequence":"additional","affiliation":[{"name":"Clinic for Surgery, Clinical and Hospital Center \u201cDr Dragisa Misovic-Dedinje\u201d, Heroja Milana Tepica 1, 11020 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miljan","family":"Milanovic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Subotica Starijeg 8, 11000 Belgrade, Serbia"},{"name":"Clinic for Surgery, Clinical and Hospital Center \u201cDr Dragisa Misovic-Dedinje\u201d, Heroja Milana Tepica 1, 11020 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Markovic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Subotica Starijeg 8, 11000 Belgrade, Serbia"},{"name":"Department of Hematology, Clinical and Hospital Center \u201cBezanijska Kosa\u201d, Dr Zorza Matea s\/n, 11080 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6094-7306","authenticated-orcid":false,"given":"Aleksandra","family":"Djokovic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Subotica Starijeg 8, 11000 Belgrade, Serbia"},{"name":"Department of Cardiology, Clinical and Hospital Center \u201cBezanijska Kosa\u201d, Dr Zorza Matea s\/n, 11080 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6242-7275","authenticated-orcid":false,"given":"Tijana","family":"Glisic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Subotica Starijeg 8, 11000 Belgrade, Serbia"},{"name":"Clinic for Gastroenterology and Hepatology, University Clinical Centre of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1944-3883","authenticated-orcid":false,"given":"Sanja","family":"Dragasevic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Subotica Starijeg 8, 11000 Belgrade, Serbia"},{"name":"Clinic for Gastroenterology and Hepatology, University Clinical Centre of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5912-0360","authenticated-orcid":false,"given":"Dusan","family":"Popovic","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Clinical and Hospital Center \u201cDr Dragisa Misovic-Dedinje\u201d, Heroja Milana Tepica 1, 11020 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, Dr Subotica Starijeg 8, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3350\/cmh.2022.0387","article-title":"Epidemiology and updated management for autoimmune liver disease","volume":"29","author":"Heo","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_2","first-page":"16408","article-title":"Variants of autoimmune liver diseases: How to diagnose and treat them?","volume":"133","author":"Janik","year":"2023","journal-title":"Pol. Achives Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jhep.2023.02.030","article-title":"Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: A coming of age or an age-ist problem?","volume":"79","author":"Ricciuto","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Freedman, B.L., Danford, C.J., Patwardhan, V., and Bonder, A. (2020). Treatment of Overlap Syndromes in Autoimmune Liver Disease: A Systematic Review and Meta-Analysis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051449"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000440705","article-title":"Worldwide incidence of autoimmune liver disease","volume":"33","author":"Jepsen","year":"2015","journal-title":"Dig Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100125","DOI":"10.1016\/j.jtauto.2021.100125","article-title":"Impact of genetic and environmental factors on autoimmune hepatitis","volume":"4","author":"Zachou","year":"2021","journal-title":"J. Transl. Autoimmun."},{"key":"ref_7","first-page":"659","article-title":"Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells","volume":"12","author":"Qiu","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00281-022-00950-8","article-title":"How genetic risk contributes to autoimmune liver disease","volume":"Volume 44","author":"Ellinghaus","year":"2022","journal-title":"Seminars in Immunopathology"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gerussi, A., Carbone, M., Asselta, R., and Invernizzi, P. (2020). Genetics of Autoimmune Liver Diseases, Springer.","DOI":"10.1007\/978-3-030-51709-0_5"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Invernizzi, F., Cilla, M., Trapani, S., Guarino, M., Cossiga, V., Gambato, M., Morelli, M.C., Morisco, F., Burra, P., and Floreani, A. (2022). Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice. J. Pers. Med., 12.","DOI":"10.3390\/jpm12060925"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00281-022-00940-w","article-title":"Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease","volume":"44","author":"Richardson","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41423-020-00568-6","article-title":"Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease","volume":"18","author":"Horst","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1007\/s10620-023-07967-5","article-title":"Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis","volume":"68","author":"Czaja","year":"2023","journal-title":"Dig. Dis. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Floreani, A., Gabbia, D., and de Martin, S. (2024). Are Gender Differences Important for Autoimmune Liver Diseases?. Life, 14.","DOI":"10.3390\/life14040500"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101878","DOI":"10.1016\/j.bpg.2023.101878","article-title":"Prognostic models and autoimmune liver diseases","volume":"67","author":"Carbone","year":"2023","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.21037\/tgh-20-266","article-title":"Primary sclerosing cholangitis","volume":"6","author":"Rabiee","year":"2021","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e25634","DOI":"10.1016\/j.heliyon.2024.e25634","article-title":"Reasons why women are more likely to develop primary biliary cholangitis","volume":"10","author":"Ma","year":"2024","journal-title":"Heliyon"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","author":"Carbone","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Richardson, N., Ng, S.T.H., and Wraith, D.C. (2020). Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01586"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/transplantology2020016","article-title":"Management of Autoimmune Liver Diseases after Liver Transplantation","volume":"2","author":"Bernal","year":"2021","journal-title":"Transplantology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5500\/wjt.v12.i3.59","article-title":"Autoimmune hepatitis and liver transplantation: Indications, and recurrent and de novo autoimmune hepatitis","volume":"12","author":"Harputluoglu","year":"2022","journal-title":"World J. Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/liv.14378","article-title":"The future of autoimmune liver diseases\u2014Understanding pathogenesis and improving morbidity and mortality","volume":"40","author":"Engel","year":"2020","journal-title":"Liver Int."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sirbe, C., Simu, G., Szabo, I., Grama, A., and Pop, T.L. (2021). Pathogenesis of Autoimmune Hepatitis-Cellular and Molecular Mechanisms. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413578"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/cld.321","article-title":"Autoimmune hepatitis: Diagnostic criteria and serological testing","volume":"3","author":"Vergani","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/1573396310666141114230147","article-title":"Autoimmune hepatitis","volume":"10","author":"Longhi","year":"2014","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_26","first-page":"6470847","article-title":"Autoimmune Hepatitis with Acute Presentation: Clinical, Biochemical, and Histological Features of 126 Patients","volume":"2022","author":"Pizarro","year":"2022","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zheng, L., Liu, Y., Shang, Y., Han, Z., and Han, Y. (2021). Clinical characteristics and treatment outcomes of acute severe autoimmune hepatitis. BMC Gastroenterol., 21.","DOI":"10.1186\/s12876-021-01653-4"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Vuerich, M., Wang, N., Kalbasi, A., Graham, J.J., and Longhi, M.S. (2021). Dysfunctional Immune Regulation in Autoimmune Hepatitis: From Pathogenesis to Novel Therapies. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.746436"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-Wide Association Study Identifies Variants Associated with Autoimmune Hepatitis Type 1","volume":"147","author":"Zwiers","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","article-title":"Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis","volume":"112","author":"Strettell","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3748\/wjg.v11.i12.1862","article-title":"Genetic distinctions between autoimmune hepatitis in Italy and North America","volume":"11","author":"Muratori","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Umemura, T., Katsuyama, Y., Yoshizawa, K., Kimura, T., Joshita, S., Komatsu, M., Matsumoto, A., Tanaka, E., and Ota, M. (2014). Human leukocyte antigen class II haplotypes affect clinical characteristics and progression of type 1 autoimmune hepatitis in Japan. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100565"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Cancado, E.L.R., Goldbaum-Crescente, J., and Terrabuio, D.R.B. (2022). HLA-related genetic susceptibility in autoimmune hepatitis according to autoantibody profile. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1032591"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1074\/jbc.M110.145870","article-title":"Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor \u03b1 (TNF\u03b1) production via increased mRNA half-life in alcoholic liver disease","volume":"286","author":"Bala","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","article-title":"MicroRNAs in liver disease","volume":"10","author":"Szabo","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2013.06.016","article-title":"The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies","volume":"46","author":"Muratori","year":"2013","journal-title":"J. Autoimmun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3748\/wjg.v29.i12.1838","article-title":"Autoimmune liver diseases and SARS-CoV-2","volume":"29","author":"Sgamato","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2021.01.021","article-title":"SARS-CoV-2 infection in patients with autoimmune hepatitis","volume":"74","author":"Marjot","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00281-022-00937-5","article-title":"B cells in autoimmune hepatitis: Bystanders or central players?","volume":"44","author":"Steinmann","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e070201","DOI":"10.1136\/bmj-2022-070201","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"380","author":"Muratori","year":"2023","journal-title":"BMJ"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"9437043","DOI":"10.1155\/2019\/9437043","article-title":"Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies","volume":"2019","author":"Sucher","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_44","first-page":"1155","article-title":"Calcineurin Inhibitors in the Treatment of Adult Autoimmune Hepatitis: A Systematic Review","volume":"10","author":"Hew","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_45","unstructured":"Pandit, S., and Samant, H. (2024). Primary Biliary Cholangitis. StatPearls, StatPearls Publishing."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e0179","DOI":"10.1097\/HC9.0000000000000179","article-title":"Primary biliary cholangitis: Epidemiology, prognosis, and treatment","volume":"7","author":"Trivella","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0034-1383727","article-title":"Role of cholangiocytes in primary biliary cirrhosis","volume":"34","author":"Lleo","year":"2014","journal-title":"Semin. Liver Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12328-015-0620-9","article-title":"Genetic factors affect the etiology, clinical characteristics and outcome of autoimmune hepatitis","volume":"8","author":"Umemura","year":"2015","journal-title":"Clin. J. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.arcmed.2014.03.002","article-title":"HLA-DR polymorphism and primary biliary cirrhosis: Evidence from a meta-analysis","volume":"45","author":"Li","year":"2014","journal-title":"Arch. Med. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1053\/gast.1997.v113.pm9352872","article-title":"Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection","volume":"113","author":"Alric","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1099\/0022-1317-80-2-409","article-title":"Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16","volume":"80","author":"Bontkes","year":"1999","journal-title":"J. Gen. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM199504203321604","article-title":"Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia","volume":"332","author":"Thursz","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12328-017-0799-z","article-title":"Genetics and epigenetics in the pathogenesis of primary biliary cholangitis","volume":"11","author":"Joshita","year":"2018","journal-title":"Clin. J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Gerussi, A., Paraboschi, E.M., Cappadona, C., Caime, C., Binatti, E., Cristoferi, L., Asselta, R., and Invernizzi, P. (2022). The Role of Epigenetics in Primary Biliary Cholangitis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094873"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/tropej\/fmm119","article-title":"Biliary cirrhosis in a child with inherited interleukin-12 deficiency","volume":"54","author":"Pulickal","year":"2008","journal-title":"J. Trop. Pediatr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.3390\/ijms16036432","article-title":"Primary biliary cirrhosis is a generalized autoimmune epithelitis","volume":"16","author":"Gao","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bpg.2018.05.012","article-title":"Pathophysiology of primary biliary cholangitis","volume":"34","author":"Gulamhusein","year":"2018","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3748\/wjg.v29.i12.1795","article-title":"Role of autoantibodies in the clinical management of primary biliary cholangitis","volume":"29","author":"Rigopoulou","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22736","article-title":"Apotopes and the biliary specificity of primary biliary cirrhosis","volume":"49","author":"Lleo","year":"2009","journal-title":"Hepatology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"526518","DOI":"10.1155\/2015\/526518","article-title":"SP140L, an Evolutionarily Recent Member of the SP100 Family, Is an Autoantigen in Primary Biliary Cirrhosis","volume":"2015","author":"Saare","year":"2015","journal-title":"J. Immunol. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.clinre.2020.03.026","article-title":"Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators","volume":"44","author":"Qian","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ajg.2009.596","article-title":"PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis","volume":"105","author":"Granito","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/jhep.2002.33634","article-title":"Defective regulation of cholangiocyte Cl-\/HCO3(-) and Na+\/H+ exchanger activities in primary biliary cirrhosis","volume":"35","author":"Melero","year":"2002","journal-title":"Hepatology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3-umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Yang, Y., He, X., Rojas, M., Leung, P.S.C., and Gao, L. (2023). Mechanism-based target therapy in primary biliary cholangitis: Opportunities before liver cirrhosis?. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1184252"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.32172","article-title":"Coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants","volume":"75","author":"Yang","year":"2021","journal-title":"Hepatology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/hep.24748","article-title":"Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid","volume":"55","author":"Tsuda","year":"2011","journal-title":"Hepatology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"102897","DOI":"10.1016\/j.jaut.2022.102897","article-title":"Dual b-cell targeting therapy ameliorates autoimmune cholangitis","volume":"132","author":"Zhang","year":"2022","journal-title":"J. Autoimmun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00281-009-0154-7","article-title":"The immunobiology of primary sclerosing cholangitis","volume":"31","author":"Aron","year":"2009","journal-title":"Semin. Immunopathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis\u2014A comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coph.2021.11.003","article-title":"Emerging drugs for the treatment of primary sclerosing cholangitis","volume":"62","author":"Abbas","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-933559","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"26","author":"Vierling","year":"2006","journal-title":"Semin. Liver Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2023.09.031","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?","volume":"80","author":"Bergquist","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/his.14677","article-title":"Novel histological scoring for predicting disease outcome in primary sclerosing cholangitis","volume":"81","author":"Boyd","year":"2022","journal-title":"Histopathology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2021.03.029","article-title":"Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis","volume":"75","author":"Reich","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"Banales","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_82","first-page":"293","article-title":"Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment","volume":"14","author":"Tabibian","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3748\/wjg.v26.i21.2768","article-title":"Gut microbiome in primary sclerosing cholangitis: A review","volume":"26","author":"Little","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrgastro.2016.154","article-title":"Genetics of primary sclerosing cholangitis and pathophysiological implications","volume":"14","author":"Jiang","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s12276-023-01042-9","article-title":"Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): A condition exemplifying the crosstalk of the gut-liver axis","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/2040622315605821","article-title":"A review of the medical treatment of primary sclerosing cholangitis in the 21st century","volume":"7","author":"Goode","year":"2016","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Tabibian, J.H., Talwalkar, J.A., and Lindor, K.D. (2013). Role of the microbiota and antibiotics in primary sclerosing cholangitis. BioMed Res. Int., 2013.","DOI":"10.1155\/2013\/389537"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/1863\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:39:57Z","timestamp":1760027997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/1863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":88,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["ijms26051863"],"URL":"https:\/\/doi.org\/10.3390\/ijms26051863","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]}}}